Endovascular treatment devices and methods

Details for Australian Patent Application No. 2005207046 (hide)

Owner The Biometrix Corporation

Inventors Friedman, Craig D.; Kula, John; Datta, Arindam; Jordan, Maybelle; Sanderson, George; Sepetka, Ivan

Agent Mallesons

Pub. Number AU-A-2005207046

PCT Pub. Number WO2005/070015

Priority 60/538,597 23.01.04 US; 10/900,982 27.07.04 US

Filing date 24 January 2005

Wipo publication date 4 August 2005

International Classifications

A61F 2/20 (2006.01) Filters - Larynxes

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/070015 Priority application(s): WO2005/070015

14 December 2006 Change of Name(s) of Applicant(s), Section 104

  The Biometrix Corporation., Has no value - Entry Incomplete The name of the applicant has been changed to Biomerix Corporation.

19 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005207053-Expression of ApoA-1 and variants thereof using spliceosome mediated RNA trans-splicing

2005207042-Improved modalities for the treatment of degenerative diseases of the retina